These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 11884563

  • 1. Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response.
    Faber M, Pulmanausahakul R, Hodawadekar SS, Spitsin S, McGettigan JP, Schnell MJ, Dietzschold B.
    J Virol; 2002 Apr; 76(7):3374-81. PubMed ID: 11884563
    [Abstract] [Full Text] [Related]

  • 2. In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife.
    Dietzschold ML, Faber M, Mattis JA, Pak KY, Schnell MJ, Dietzschold B.
    Vaccine; 2004 Dec 09; 23(4):518-24. PubMed ID: 15530701
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Development of rabies DNA vaccine using a recombinant plasmid.
    Rai N, Kaushik P, Rai A.
    Acta Virol; 2005 Dec 09; 49(3):207-10. PubMed ID: 16178518
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
    Cenna J, Tan GS, Papaneri AB, Dietzschold B, Schnell MJ, McGettigan JP.
    Vaccine; 2008 Nov 25; 26(50):6405-14. PubMed ID: 18804506
    [Abstract] [Full Text] [Related]

  • 9. Biological and immunogenic properties of rabies virus glycoprotein expressed by canine herpesvirus vector.
    Xuan X, Tuchiya K, Sato I, Nishikawa Y, Onoderaz Y, Takashima Y, Yamamoto A, Katsumata A, Iwata A, Ueda S, Mikami T, Otsuka H.
    Vaccine; 1998 Nov 25; 16(9-10):969-76. PubMed ID: 9682345
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
    Navid MT, Li Y, Zhou M, Cui M, Fu ZF, Tang L, Zhao L.
    Arch Virol; 2016 Oct 25; 161(10):2863-70. PubMed ID: 27438075
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of single and dual siRNAs targeting rabies virus glycoprotein and nucleoprotein genes for inhibition of virus multiplication in vitro.
    Meshram CD, Singh NK, Sonwane AA, Pawar SS, Mishra BP, Chaturvedi VK, Saini M, Singh RP, Gupta PK.
    Arch Virol; 2013 Nov 25; 158(11):2323-32. PubMed ID: 23754741
    [Abstract] [Full Text] [Related]

  • 12. [Recombinant replication-defective adenovirus based rabies vaccine].
    Li WH, Zhang Y, Wang SH, Liu L, Yang F.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec 25; 25(6):650-4. PubMed ID: 14714304
    [Abstract] [Full Text] [Related]

  • 13. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
    Gupta PK, Sharma S, Walunj SS, Patil AA, Rai A, Saini M.
    Acta Virol; 2006 Dec 25; 50(2):87-92. PubMed ID: 16808325
    [Abstract] [Full Text] [Related]

  • 14. Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV.
    Wirblich C, Schnell MJ.
    J Virol; 2011 Jan 25; 85(2):697-704. PubMed ID: 21068252
    [Abstract] [Full Text] [Related]

  • 15. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures.
    Morimoto K, Hooper DC, Spitsin S, Koprowski H, Dietzschold B.
    J Virol; 1999 Jan 25; 73(1):510-8. PubMed ID: 9847357
    [Abstract] [Full Text] [Related]

  • 16. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein.
    Fujii H, Takita-Sonoda Y, Mifune K, Hirai K, Nishizono A, Mannen K.
    J Gen Virol; 1994 Jun 25; 75 ( Pt 6)():1339-44. PubMed ID: 8207400
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.
    Kim HH, Yang DK, Nah JJ, Song JY, Cho IS.
    Virol J; 2017 Jun 24; 14(1):122. PubMed ID: 28646885
    [Abstract] [Full Text] [Related]

  • 18. A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies.
    Borhani K, Ajorloo M, Bamdad T, Mozhgani SH, Ghaderi M, Gholami AR.
    Arch Iran Med; 2015 Apr 24; 18(4):223-7. PubMed ID: 25841942
    [Abstract] [Full Text] [Related]

  • 19. Silver-haired bat rabies virus variant does not induce apoptosis in the brain of experimentally infected mice.
    Yan X, Prosniak M, Curtis MT, Weiss ML, Faber M, Dietzschold B, Fu ZF.
    J Neurovirol; 2001 Dec 24; 7(6):518-27. PubMed ID: 11704884
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity.
    Pulmanausahakul R, Faber M, Morimoto K, Spitsin S, Weihe E, Hooper DC, Schnell MJ, Dietzschold B.
    J Virol; 2001 Nov 24; 75(22):10800-7. PubMed ID: 11602721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.